Showing results (231-240 of 318) with videos related to

Sort By:
Pageof 32
Therapeutic Advances in Medical Oncology|March 7, 2022
First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2-altered NSCLC: a retrospective real-world POLISH studyGuangjian Yang, Yaning Yang, Runze Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2012
Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancerLuhua Wang, Shixiu Wu, Guangfei Ou, et al.
Cancer Medicine|March 14, 2020
Crizotinib vs platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer with different ROS1 fusion variantsHaiyan Xu, Quan Zhang, Li Liang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 12, 2013
[Efficacy of chemotherapy after EGFR-TKIs resistance in 191 patients with Unknow EGFR gene mutation in advanced lung adenocarcinoma]Ping He, Yan Wang, Sheng Yang, et al.
The Heart Surgery Forum|November 25, 2020
The MicroRNA-210/Casp8ap2 Pathway Alleviates Hypoxia-Induced Injury in Myocardial Cells by Regulating Apoptosis and AutophagyKunsheng Li, Jun Pan, Qiuchang Li, et al.
Clinical Lung Cancer|January 18, 2018
Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung CancerTian Qiu, Weihua Li, Tongtong Zhang, et al.
In Vitro Cellular & Developmental Biology. Animal|September 30, 2022
Expression patterns and correlation analyses of muscle-specific genes in the process of sheep myoblast differentiationHejie Wang, Minmin Dou, Jun Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 30, 2019
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort studyPuyuan Xing, Di Ma, Qiang Wang, et al.
Environmental Science & Technology|January 5, 2017
Enhanced Light Scattering of Secondary Organic Aerosols by Multiphase ReactionsKun Li, Junling Li, John Liggio, et al.
Research (Washington, D.C.)|April 15, 2025
Proteogenomic Characterization of High-Grade Lung Neuroendocrine Carcinoma Deciphers Molecular Diversity and Potential Biomarkers of Different Histological Subtypes in Chinese PopulationZicheng Zhang, Xi Wu, Siqi Bao, et al.
Pageof 32